<iframe src="//www.googletagmanager.com/ns.html?id=GTM-MX3DVL" height="0" width="0" style="display:none;visibility:hidden"></iframe>Pestalozzi advised Johnson & Johnson Innovation – JJDC, Inc. in connection with the IPO of Molecular Partners AG | Pestalozzi Attorneys at Law

Pestalozzi advised Johnson & Johnson Innovation – JJDC, Inc. in connection with the IPO of Molecular Partners AG

01.11.2014

Pestalozzi advised Johnson & Johnson Innovation – JJDC, Inc. as investor in connection with the pre-IPO corporate restructuring steps and the IPO of Molecular Partners AG, a Schlieren based biotech company (SIX: MOLN), which went public on SIX Swiss Exchange in November 2014.

To the top

Cookies

Close
We use cookies in order to optimally design and continuously improve our website. By continuing to use the website you consent to the use of cookies. For further information about cookies please view our data protection statement.